tag pfizer 
MedCity News
APRIL 26, 2024
The FDA has approved Beqvez, a Pfizer gene therapy developed for moderate-to-severe hemophilia B. million price tag, the same as a CSL Behring gene therapy already available for treating the inherited bleeding disorder. The one-time treatment carries a $3.5
World of DTC Marketing
FEBRUARY 19, 2021
Included in the programmatic ad errors is Pfizer, who developed a leading COVID vaccine. NewsGuard found that 67% of the COVID misinformation sites had Google advertising tags and 30% had tags from The Trade Desk. When will pharma stop using programmatic online ads? Programmatic has been a thorn in online advertisers.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Technology
AUGUST 1, 2023
Vepdegestrant was awarded the Innovation Passport designation for treating advanced or metastatic breast cancer.
World of DTC Marketing
JULY 20, 2022
Pfizer, for instance, hiked the cost of its leukemia medication Besponsa again this month, bringing its per-vial price tag to $21,056. Patients for Affordable Drugs found that between June 24 and July 5, pharmaceutical companies increased prices for 133 products.
pharmaphorum
AUGUST 25, 2022
The category is getting increasingly crowed, with Pfizer also anticipating approval of its BCMA-targeting bispecific elranatamab in the coming months, with several more multiple myeloma bispecifics coming through the pipeline from the likes of Regeneron, AbbVie, Amgen and Roche.
pharmaphorum
JULY 25, 2022
Tecvayli previously scored a priority medicines (PRiME) designation from the EMA and a breakthrough-therapy tag from the FDA. Pfizer is hot on J&J’s heels with its BCMA and CD3 bispecific antibody elranatamab, and reported phase 2 data at ASCO this year in a similarly heavily pre-treated patient population.
Pharmaceutical Technology
FEBRUARY 22, 2023
Not even two weeks ago, the likes of AstraZeneca and Pfizer voiced their support of Sanofi’s side through amicus briefs submitted to the Court. Both drugs come with a high price tag. The patent battle between Amgen and Sanofi over their cholesterol-lowering antibodies has divided big pharma in the past months.
Expert insights. Personalized for you.
107 
Let's personalize your content